A. Rasmussen

发表

Substrates of human hepatic cytochrome P450 3A4.

A. Li, D. Kaminski, D L Kaminski, 1995, Toxicology.

Rifampicin induction of lidocaine metabolism in cultured human hepatocytes.

A. Li, D. Kaminski, A. Rasmussen, 1995, The Journal of pharmacology and experimental therapeutics.

Targeting of O6-MeG DNA methyltransferase (MGMT) to mitochondria protects against alkylation induced cell death.

L. Rasmussen, A. Rasmussen, 2005, Mitochondrion.

Metabolism of some kava pyrones in the rat.

R. Hänsel, A. Rasmussen, E. Solheim, 1979, Xenobiotica; the fate of foreign compounds in biological systems.

Identification of Factors Interacting with hMSH2 and hMLH1 in the Fetal Liver and Investigations of how Mitochondrial Dysfunction Creates a Mutator Phenotype

A. Rasmussen, 2001 .

Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin.

A. Li, J. Gorski, S. Hall, 1997, Chemico-biological interactions.

Genome‐Wide Analysis of Signal Transducers and Regulators of Mitochondrial Dysfunction in Saccharomyces cerevisiae

L. Rasmussen, Keshav K. Singh, A. Rasmussen, 2004, Annals of the New York Academy of Sciences.

Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus.

L. Rasmussen, Keshav K. Singh, P. Goswami, 2003, Mutagenesis.

Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae.

L. Rasmussen, A. Chatterjee, Keshav K. Singh, 2003, Nucleic acids research.

Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis.

L. Rasmussen, F. Nielsen, M. Rasmussen, 2000, Mutation research.